Orthobiologics Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2027
Published On : August 2017 Pages : 116 Category: Medical Devices Report Code : HC06151
Industry Trend Analysis
The orthobiologics market is expected to be around $10 billion by 2027. The market is primarily driven by factors such as increasing number of orthopedic surgical procedures performed worldwide due to rising incidence of accidents and sports related injuries. Increasing prevalence of geriatric population around the world is another key factor contributing to the market growth. According to the 2017 World Aging Population report by the United Nations (UN), between 2017 and 2030, the global population aged 60 years and over is expected to grow by 56% from 901 million to 1.4 billion. This number is projected to further rise up to 2.1 billion by 2050. As geriatric people are more susceptible to orthopedic and spinal disorders, such high prevalence will largely contribute to the growth of orthobiologics market during the forecast period. However, factors such as high cost of the procedures and stringent regulatory approval processes can hinder the growth of orthobiologics market during the forecast period.
Product Outlook and Trend Analysis
Viscosupplementation segment dominated the global orthobiologics market in 2017 owing to high adoption of these products for diseases such as hip degenerative joint disease and osteoarthritis. The growth of this market can be further attributed to growing popularity of knee treatments along with the ability of viscosupplementation to act as an effective pain killer as compared to others. Synthetic bone substitutes segment along with stem cell based products is expected to witness significant growth during the forecast period as a result of their reduced cost and associated benefits such as eliminated risk of disease transmission and quick recovery.
Application Outlook and Trend Analysis
Spinal fusion segment accounted for the major share of the overall market in 2017 as the therapy delivers high bone stability along with rapid healing of the bones thus facilitating quick recovery for long-term spinal disorders. In spinal fusion, the rapid stimulation of cells initiates effective bone formation. Moreover, the therapy results in reduced duration of hospital stay which is a key contributing factor to the growth of this market.
End User Outlook and Trend Analysis
Hospitals segment held a major share of the market in 2017 owing to widespread adoption of orthobiological products for various reconstructive surgeries. Furthermore, easy availability of orthobiologics in hospitals and increased emphasis on specialized patient care are expected to boost the growth of the market during the forecast period.
Regional Outlook and Trend Analysis
North America dominated the orthobiologics market in 2017 due to the abundant presence of prominent players in orthobiologics market in the region along with favorable reimbursement policies for fusion enhancement products and soft tissue healing. The Asia-Pacific orthobiologics market is expected to grow at the fastest rate over the forecast period owing to increasing healthcare expenditure in emerging countries along with rising disposable income of the people.
Competitive Insights
The major players in the orthobiologics market focus on new product development strategy to secure a competitive advantage over others. Moreover, they are involved in strategic collaborations, mergers and acquisitions to enhance their presence across different regional markets. For instance, in March 2017, Zimmer Biomet Holdings, Inc. secured an exclusive global distribution agreement with CelgenTek Innovations Corporation for its N-Force Fixation System and CelgenTek's iN3 cement. The agreement enabled CelgenTek to enhance its reach benefiting from Zimmer Biomet’s commercial capabilities.
Some of the key players operating in the orthobiologics market are, Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corporation, DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc.), Medtronic plc, Osiris Therapeutics, Inc., Kuros Biosciences AG, Globus Medical Inc., Wright Medical Group N.V, Arthrex, Inc., ISTO Technologies, Inc., CollPlant Ltd, OsteoMed and NuVasive, Inc.
Market Opportunities
The key opportunity for the players operating in orthobiologics market lies in the development of advanced reconstruction and repair products. Moreover, expanding distribution capabilities to explore and capture new marketplaces will facilitate a competitive edge for the major players in coming years. Increasing demand for patient specific therapy and rising incidence of spine related disorders will offer lucrative growth opportunities for the orthobiologics market in emerging countries during the next few years.
Orthobiologics Market Segmentation:
By Product:
- Demineralized Bone Matrix (DBM)
- Viscosupplementation
- Bone Morphogenetic Protein (BMP)
- Allograft
- Stem Cell Therapy
- Synthetic Bone Substitutes
By Application:
- Trauma Repair
- Spinal Fusion
- Reconstructive Surgery
By End User:
- Orthopedic Clinics
- Hospitals
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Orthobiologics Market By Product, Estimates and Forecast, 2017-2027 ($Million)
- Demineralized Bone Matrix (DBM)
- Viscosupplementation
- Bone Morphogenetic Protein (BMP)
- Allograft
- Stem Cell Therapy
- Synthetic Bone Substitutes
- Orthobiologics Market By Application, Estimates and Forecast, 2017-2027 ($Million)
- Trauma Repair
- Spinal Fusion
- Reconstructive Surgery
- Orthobiologics Market By End User, Estimates and Forecast, 2017-2027 ($Million)
- Orthopedic Clinics
- Hospitals
- Orthobiologics Market By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Orthobiologics Market, By Country
- North America Orthobiologics Market, By Product
- North America Orthobiologics Market, By Application
- North America Orthobiologics Market, By End User
- U.S. Orthobiologics Market, By Product
- U.S. Orthobiologics Market, By Application
- U.S. Orthobiologics Market, By End User
- Canada Orthobiologics Market, By Product
- Canada Orthobiologics Market, By Application
- Canada Orthobiologics Market, By End User
- Mexico Orthobiologics Market, By Product
- Mexico Orthobiologics Market, By Application
- Mexico Orthobiologics Market, By End User
-
- Europe
- Europe Orthobiologics Market, By Country
- Europe Orthobiologics Market, By Product
- Europe Orthobiologics Market, By Application
- Europe Orthobiologics Market, By End User
- Germany Orthobiologics Market, By Product
- Germany Orthobiologics Market, By Application
- Germany Orthobiologics Market, By End User
- France Orthobiologics Market, By Product
- France Orthobiologics Market, By Application
- France Orthobiologics Market, By End User
- UK Orthobiologics Market, By Product
- UK Orthobiologics Market, By Application
- UK Orthobiologics Market, By End User
- Italy Orthobiologics Market, By Product
- Italy Orthobiologics Market, By Application
- Italy Orthobiologics Market, By End User
- Spain Orthobiologics Market, By Product
- Spain Orthobiologics Market, By Application
- Spain Orthobiologics Market, By End User
- Rest of Europe Orthobiologics Market, By Product
- Rest of Europe Orthobiologics Market, By Application
- Rest of Europe Orthobiologics Market, By End User
-
- Asia-Pacific
- Asia-Pacific Orthobiologics Market, By Country
- Asia-Pacific Orthobiologics Market, By Product
- Asia-Pacific Orthobiologics Market, By Application
- Asia-Pacific Orthobiologics Market, By End User
- Japan Orthobiologics Market, By Product
- Japan Orthobiologics Market, By Application
- Japan Orthobiologics Market, By End User
- China Orthobiologics Market, By Product
- China Orthobiologics Market, By Application
- China Orthobiologics Market, By End User
- Australia Orthobiologics Market, By Product
- Australia Orthobiologics Market, By Application
- Australia Orthobiologics Market, By End User
- India Orthobiologics Market, By Product
- India Orthobiologics Market, By Application
- India Orthobiologics Market, By End User
- South Korea Orthobiologics Market, By Product
- South Korea Orthobiologics Market, By Application
- South Korea Orthobiologics Market, By End User
- Rest of Asia-Pacific Orthobiologics Market, By Product
- Rest of Asia-Pacific Orthobiologics Market, By Application
- Rest of Asia-Pacific Orthobiologics Market, By End User
- Asia-Pacific
-
- Rest of the World
- Rest of the World Orthobiologics Market, By Country
- Rest of the World Orthobiologics Market, By Product
- Rest of the World Orthobiologics Market, By Application
- Rest of the World Orthobiologics Market, By End User
- Brazil Orthobiologics Market, By Product
- Brazil Orthobiologics Market, By Application
- Brazil Orthobiologics Market, By End User
- South Africa Orthobiologics Market, By Product
- South Africa Orthobiologics Market, By Application
- South Africa Orthobiologics Market, By End User
- Saudi Arabia Orthobiologics Market, By Product
- Saudi Arabia Orthobiologics Market, By Application
- Saudi Arabia Orthobiologics Market, By End User
- Turkey Orthobiologics Market, By Product
- Turkey Orthobiologics Market, By Application
- Turkey Orthobiologics Market, By End User
- United Arab Emirates Orthobiologics Market, By Product
- United Arab Emirates Orthobiologics Market, By Application
- United Arab Emirates Orthobiologics Market, By End User
- Others Orthobiologics Market, By Product
- Others Orthobiologics Market, By Application
- Others Orthobiologics Market, By End User
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Geriatric Population
3.3.1.2. Rising Incidence of Sports Injuries
3.3.1.3. Increasing Demand for Minimally Invasive Surgical Procedures
3.3.1.4. Surge in the Number of Orthopedic Surgeries
3.3.2. Restraints
3.3.2.1. High Cost of Orthobiologics Related Surgeries
3.3.2.2. Stringent Regulatory Approval Process
3.3.3. Opportunities
3.3.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Orthobiologics Market, By Product
4.1. Introduction
4.2. Orthobiologics Market Assessment and Forecast, By Product, 2017-2027
4.3. Demineralized Bone Matrix
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Viscosupplementation
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5. Bone Morphogenetic Protein
4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.6. Allograft
4.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.7. Stem Cell Therapy
4.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.8. Synthetic Bone Substitutes
4.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Orthobiologics Market, By Application
5.1. Introduction
5.2. Orthobiologics Market Assessment and Forecast, By Application, 2017-2027
5.3. Trauma Repair
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4. Spinal Fusion
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5. Reconstructive Surgery
5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Orthobiologics Market, By End User
6.1. Introduction
6.2. Orthobiologics Market Assessment and Forecast, By End User, 2017-2027
6.3. Orthopedic Clinics
6.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.4. Hospitals
6.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7. Orthobiologics Market, By Region
7.1. Introduction
7.2. Orthobiologics Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7.3. North America
7.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.1. U.S.
7.3.4.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.3.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.2. Canada
7.3.4.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.3.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.3. Mexico
7.3.4.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.3.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4. Europe
7.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.1. Germany
7.4.4.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.2. France
7.4.4.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.3. UK
7.4.4.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.4. Italy
7.4.4.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.5. Spain
7.4.4.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.5.2. Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.6. Russia
7.4.4.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.7. Rest of Europe
7.4.4.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.4.4.7.2. Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.7.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5. Asia-Pacific
7.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.1. Japan
7.5.4.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.2. China
7.5.4.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.3. Australia
7.5.4.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.4. India
7.5.4.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.5. South Korea
7.5.4.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.6. Rest of Asia-Pacific
7.5.4.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.5.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6. Rest of the World
7.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.1. Brazil
7.6.4.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.2. Turkey
7.6.4.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.3. Saudi Arabia
7.6.4.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.4. South Africa
7.6.4.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.5. United Arab Emirates
7.6.4.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.6. Others
7.6.4.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
7.6.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8. Company Profiles
8.1. Bone Biologics Corporation
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Key Financials
8.1.4. Strategic Developments
8.2. Bioventus LLC.
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Strategic Developments
8.3. RTI Surgical, Inc.
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Key Financials
8.3.4. Strategic Developments
8.4. Smith & Nephew PLC
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Key Financials
8.4.4. Strategic Developments
8.5. Stryker Corporation
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Key Financials
8.5.4. Strategic Developments
8.6. Johnson & Johnson Services, Inc.
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Key Financials
8.6.4. Strategic Developments
8.7. Medtronic plc
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Key Financials
8.7.4. Strategic Developments
8.8. Osiris Therapeutics, Inc.
8.8.1. Business Overview
8.8.2. Product Portfolio
8.8.3. Key Financials
8.8.4. Strategic Developments
8.9. Globus Medical Inc.
8.9.1. Business Overview
8.9.2. Product Portfolio
8.9.3. Key Financials
8.9.4. Strategic Developments
8.10. Wright Medical Group N.V
8.10.1. Business Overview
8.10.2. Product Portfolio
8.10.3. Key Financials
8.10.4. Strategic Developments
8.11. NuVasive, Inc.
8.11.1. Business Overview
8.11.2. Product Portfolio
8.11.3. Key Financials
8.11.4. Strategic Developments
8.12. Arthrex, Inc.
8.12.1. Business Overview
8.12.2. Product Portfolio
8.12.3. Strategic Developments
8.13. Kuros Biosciences AG
8.13.1. Business Overview
8.13.2. Product Portfolio
8.13.3. Key Financials
8.13.4. Strategic Developments
8.14. ISTO Technologies, Inc.
8.14.1. Business Overview
8.14.2. Product Portfolio
8.14.3. Strategic Developments
8.15. CollPlant Ltd
8.15.1. Business Overview
8.15.2. Product Portfolio
8.15.3. Key Financials
8.15.4. Strategic Developments
8.16. OsteoMed
8.16.1. Business Overview
8.16.2. Product Portfolio
8.16.3. Strategic Developments
8.17. Musculoskeletal Transplant Foundation
8.17.1. Business Overview
8.17.2. Product Portfolio
8.17.3. Strategic Developments
8.18. Seikagaku Corporation
8.18.1. Business Overview
8.18.2. Product Portfolio
8.18.3. Key Financials
8.18.4. Strategic Developments
8.19. AlloSource
8.19.1. Business Overview
8.19.2. Product Portfolio
8.19.3. Strategic Developments
List of Tables
Table 1.Orthobiologics Market, By Product, 2017-2025, ($Million)
Table 2.Demineralized Bone Matrix Market, By Region, 2017-2025, ($Million)
Table 3.Viscosupplementation Market, By Region, 2017-2025, ($Million),
Table 4.Bone Morphogenetic Protein Market, By Region, 2017-2025, ($Million)
Table 5.Allograft Market, By Region, 2017-2025, ($Million)
Table 6.Stem Cell Therapy Market, By Region, 2017-2025, ($Million)
Table 7.Synthetic Bone Substitutes Market, By Region, 2017-2025, ($Million)
Table 8.Orthobiologics Market, By Application, 2017-2025, ($Million)
Table 9.Trauma Repair Market, By Region, 2017-2025, ($Million)
Table 10.Spinal Fusion Market, By Region, 2017-2025, ($Million),
Table 11.Reconstructive Surgery Market, By Region ($Million), 2017-2025
Table 12.Orthobiologics Market, By End User, 2017-2025, ($Million)
Table 13.Orthopedic Clinics Market, By Region ($Million), 2017-2025
Table 14.Hospitals Market, By Region, 2017-2025, ($Million)
Table 15.Orthobiologics Market, By Region, 2017-2025 ($Million)
Table 16.North America Orthobiologics Market, By Country, 2017-2025 ($Million)
Table 17.North America Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 18.North America Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 19.North America Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 20.U.S. Orthobiologics market, by Product, 2017-2025 ($Million)
Table 21.U.S. Orthobiologics market, by Application, 2017-2025 ($Million)
Table 22.U.S. Orthobiologics market, by End User, 2017-2025 ($Million)
Table 23.Canada Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 24.Canada Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 25.Canada Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 26.Mexico Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 27.Mexico Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 28.Mexico Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 29.Europe Orthobiologics Market, By Country, 2017-2025 ($Million)
Table 30.Europe Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 31.Europe Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 32.Europe Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 33.Germany Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 34.Germany Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 35.Germany Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 36.France Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 37.France Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 38.France Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 39.UK Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 40.UK Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 41.UK Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 42.Italy Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 43.Italy Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 44.Italy Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 45.Spain Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 46.Spain Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 47.Spain Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 48.Russia Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 49.Russia Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 50.Russia Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 51.Rest of Europe Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 52.Rest of Europe Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 53.Rest of Europe Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 54.Asia-Pacific Orthobiologics Market, By Country, 2017-2025 ($Million)
Table 55.Asia-Pacific Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 56.Asia-Pacific Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 57.Asia-Pacific Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 58.Japan Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 59.Japan Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 60.Japan Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 61.China Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 62.China Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 63.China Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 64.Australia Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 65.Australia Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 66.Australia Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 67.India Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 68.India Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 69.India Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 70.South Korea Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 71.South Korea Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 72.South Korea Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 73.Rest of Asia-Pacific Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 74.Rest of Asia-Pacific Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 75.Rest of Asia-Pacific Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 76.Rest of the World Orthobiologics Market, By Country, 2017-2025 ($Million)
Table 77.Rest of the World Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 78.Rest of the World Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 79.Rest of the World Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 80.Brazil Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 81.Brazil Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 82.Brazil Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 83.Turkey Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 84.Turkey Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 85.Turkey Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 86.Saudi Arabia Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 87.Saudi Arabia Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 88.Saudi Arabia Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 89.South Africa Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 90.South Africa Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 91.South Africa Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 92.United Arab Emirates Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 93.United Arab Emirates Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 94.United Arab Emirates Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 95.Others Orthobiologics Market, By Product, 2017-2025 ($Million)
Table 96.Others Orthobiologics Market, By Application, 2017-2025 ($Million)
Table 97.Others Orthobiologics Market, By End User, 2017-2025 ($Million)
Table 98.Bone Biologics Corporation: Key Strategic Developments, 2017-2017
Table 99.Bioventus LLC.: Key Strategic Developments, 2017-2017
Table 100.RTI Surgical, Inc.: Key Strategic Developments, 2017-2017
Table 101.Smith & Nephew PLC: Key Strategic Developments, 2017-2017
Table 102.DePuy Synthes: Key Strategic Developments, 2017-2017
Table 103.Medtronic plc: Key Strategic Developments, 2017-2017
Table 104.Osiris Therapeutics, Inc.: Key Strategic Developments, 2017-2017
Table 105.Globus Medical Inc.: Key Strategic Developments, 2017-2017
Table 106.Wright Medical Group N.V: Key Strategic Developments, 2017-2017
Table 107.NuVasive, Inc.: Key Strategic Developments, 2017-2017
Table 108.Stryker Corporation: Key Strategic Developments, 2017-2017
Table 109.Arthrex, Inc.: Key Strategic Developments, 2017-2017
Table 110.ISTO Technologies, Inc.: Key Strategic Developments, 2017-2017
Table 111.CollPlant Ltd: Key Strategic Developments, 2017-2017
Table 112.Kuros Biosciences AG: Key Strategic Developments, 2017-2017
Table 113.OsteoMed: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Orthobiologics Market Share, By Product, 2017 & 2025
Figure 2.Orthobiologics Market, By Application, 2017 ($Million)
Figure 3.Orthobiologics Market, By End User, 2017 ($Million)
Figure 4.Orthobiologics Market, By Region, 2017 ($Million)
Figure 5.Bone Biologics Corporation: Net Revenues, 2017-2017 ($Million)
Figure 6.Bone Biologics Corporation: Net Revenue Share, By Segment, 2017
Figure 7.Bone Biologics Corporation: Net Revenue Share, By Geography, 2017
Figure 8.RTI Surgical, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 9.RTI Surgical, Inc.: Net Revenue Share, By Segment, 2017
Figure 10.RTI Surgical, Inc.: Net Revenue Share, By Geography, 2017
Figure 11.Smith & Nephew PLC: Net Revenues, 2017-2017 ($Million)
Figure 12.Smith & Nephew PLC: Net Revenue Share, By Segment, 2017
Figure13.Smith & Nephew PLC: Net Revenue Share, By Geography, 2017
Figure14.Johnson & Johnson Services, Inc.: Net Revenues, 2017-2017 ($Million)
Figure15.Johnson & Johnson Services, Inc.: Net Revenue Share, By Segment, 2017
Figure16.Johnson & Johnson Services, Inc.: Net Revenue Share, By Geography, 2017
Figure 17.Stryker Corporation: Net Revenues, 2017-2017 ($Million)
Figure18.Stryker Corporation: Net Revenue Share, By Segment, 2017
Figure 19.Stryker Corporation: Net Revenue Share, By Geography, 2017
Figure 20.Medtronic plc: Net Revenues, 2017-2017 ($Million)
Figure 21.Medtronic plc: Net Revenue Share, By Segment, 2017
Figure 22.Medtronic plc: Net Revenue Share, By Geography, 2017
Figure 23.Osiris Therapeutics, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 24.Osiris Therapeutics, Inc.: Net Revenue Share, By Segment, 2017
Figure 25.Osiris Therapeutics, Inc.: Net Revenue Share, By Geography, 2017
Figure 26.Globus Medical Inc.: Net Revenues, 2017-2017 ($Million)
Figure 27.Globus Medical Inc.: Net Revenue Share, By Segment, 2017
Figure 28.Globus Medical Inc.: Net Revenue Share, By Geography, 2017
Figure 29.Wright Medical Group N.V: Net Revenues, 2017-2017 ($Million)
Figure 30.Wright Medical Group N.V: Net Revenue Share, By Segment, 2017
Figure 31.Wright Medical Group N.V: Net Revenue Share, By Geography, 2017
Figure 32.NuVasive, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 33.NuVasive, Inc.: Net Revenue Share, By Segment, 2017
Figure 34.NuVasive, Inc.: Net Revenue Share, By Geography, 2017
Figure 35.CollPlant Ltd: Net Revenues, 2017-2017 ($Million)
Figure 36.CollPlant Ltd: Net Revenue Share, By Segment, 2017
Figure 37.CollPlant Ltd: Net Revenue Share, By Geography, 2017
Figure 38.Kuros Biosciences AG: Net Revenues, 2017-2017 ($Million)
Figure 39.Kuros Biosciences AG: Net Revenue Share, By Segment, 2017
Figure 40.Kuros Biosciences AG: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|